002172 澳洋健康
2026/06 - 中期2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)12.85326.60135.51871.964-28.627
总资产报酬率 ROA (%)1.3512.1501.8902.008-0.471
投入资产回报率 ROIC (%)1.8633.0462.6872.754-0.681

边际利润分析
销售毛利率 (%)12.04413.69213.38613.48513.940
营业利润率 (%)3.9543.5623.3643.7720.412
息税前利润/营业总收入 (%)5.8745.2604.8174.7313.166
净利润/营业总收入 (%)2.9352.3182.0522.312-0.778

收益指标分析
经营活动净收益/利润总额(%)79.405105.16491.05979.409-519.666
价值变动净收益/利润总额(%)-1.2323.106-2.01429.6901,647.544
营业外收支净额/利润总额(%)6.245-7.806-3.732-17.216963.344

偿债能力分析
流动比率 (X)0.6200.6080.6540.6450.723
速动比率 (X)0.5400.5210.5670.5550.653
资产负债率 (%)89.84491.20894.38296.66299.010
带息债务/全部投入资本 (%)84.51384.06482.61593.11293.651
股东权益/带息债务 (%)17.95516.40311.3456.3662.331
股东权益/负债合计 (%)12.46210.7796.9494.3331.648
利息保障倍数 (X)3.5452.6893.0603.1260.985

营运能力分析
应收账款周转天数 (天)65.43458.35352.20150.157135.986
存货周转天数 (天)31.93432.65334.42334.36735.207